Wagayama H - Search Results

1

Cytoplasmic p21(WAF1/CIP1) expression in human hepatocellular carcinomas.

Shiraki K, Wagayama H. Shiraki K, et al. Among authors: wagayama h. Liver Int. 2006 Oct;26(8):1018-9. doi: 10.1111/j.1478-3231.2006.01320.x. Liver Int. 2006. PMID: 16953844 No abstract available.

2

High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases.

Wagayama H, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Yamanaka T, Takase K, Nakano T. Wagayama H, et al. Hum Pathol. 2002 Apr;33(4):429-34. doi: 10.1053/hupa.2002.124724. Hum Pathol. 2002. PMID: 12055678

3

p21WAF1/CTP1 expression and hepatitis virus type.

Wagayama H, Shiraki K, Yamanaka T, Sugimoto K, Ito T, Fujikawa K, Takase K, Nakano T. Wagayama H, et al. Dig Dis Sci. 2001 Oct;46(10):2074-9. doi: 10.1023/a:1011977923941. Dig Dis Sci. 2001. PMID: 11680578

4

CD40 expression in HCV-associated chronic liver diseases.

Shiraki K, Sugimoto K, Okano H, Wagayama H, Fujikawa K, Yamanaka T, Ito T, Ohmori S, Sakai T, Takase K, Nakano T. Shiraki K, et al. Among authors: wagayama h. Int J Mol Med. 2006 Oct;18(4):559-63. Int J Mol Med. 2006. PMID: 16964404

5

High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases.

Ohmori S, Shiraki K, Sugimoto K, Sakai T, Fujikawa K, Wagayama H, Takase K, Nakano T. Ohmori S, et al. Among authors: wagayama h. Hum Pathol. 2001 Dec;32(12):1363-70. doi: 10.1053/hupa.2001.29678. Hum Pathol. 2001. PMID: 11774170

6

Liver abscess associated with adult chronic granulomatous disease.

Wagayama H, Shiraki K. Wagayama H, et al. J Hepatol. 2000 Nov;33(5):856. doi: 10.1016/s0168-8278(00)80322-0. J Hepatol. 2000. PMID: 11097499 No abstract available.

7

Pancreatic cancer with chylous ascites demonstrated by lymphoscintigraphy: successful treatment with peritoneovenous shunting.

Wagayama H, Tanaka T, Shimomura M, Ogura K, Shiraki K. Wagayama H, et al. Dig Dis Sci. 2002 Aug;47(8):1836-8. doi: 10.1023/a:1016461015632. Dig Dis Sci. 2002. PMID: 12184538

8

Detection of precore-mutant hepatitis B virus genome in patients with acute and fulminant hepatitis using mutation site-specific assay (MSSA).

Shiraki K, Hamada M, Sugimoto K, Ito T, Yamanaka T, Wagayama H, Shimizu A, Makino Y, Takase K, Nakano T, Tameda Y. Shiraki K, et al. Among authors: wagayama h. Hepatogastroenterology. 2002 Sep-Oct;49(47):1352-6. Hepatogastroenterology. 2002. PMID: 12239941

9

Fatal fulminant hepatic failure associated with benzbromarone.

Wagayama H, Shiraki K, Sugimoto K, Fujikawa K, Shimizu A, Takase K, Nakano T, Tameda Y. Wagayama H, et al. J Hepatol. 2000 May;32(5):874. doi: 10.1016/s0168-8278(00)80263-9. J Hepatol. 2000. PMID: 10845680 No abstract available.

10

Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels.

Masuoka H, Kamei S, Wagayama H, Ozaki M, Kawasaki A, Tanaka T, Kitamura M, Katoh S, Shintani U, Misaki M, Sugawa M, Ito M, Nakano T. Masuoka H, et al. Among authors: wagayama h. Am Heart J. 2000 Feb;139(2 Pt 1):305-10. doi: 10.1067/mhj.2000.100184. Am Heart J. 2000. PMID: 10650304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page